Foundation Medical Partners Welcomes Kevin Sharer as
Sharer Brings Operational Expertise to Investment
ROWAYTON, CT - March 5, 2013 - Foundation Medical Partners, a
national healthcare venture capital investment firm, today announced that Kevin
Sharer has joined the team as a Partner. Mr. Sharer joins Foundation's
healthcare investment team to assess and manage investments in the connected
health and healthcare IT sectors.
Mr. Sharer has a long and successful
track record in leadership, management, and governance roles in innovative,
fast-growing companies. Most recently, he served as Chairman and CEO of Amgen,
the world's largest biotechnology company. He was Amgen's CEO from 2000 through
2012 and served as its chairman since 2001. He was President and Chief Operating
Officer of Amgen from 1992 to 2000 and was a director since 1992. Under Mr.
Sharerıs leadership as CEO, Amgen successfully launched nine products and
completed the biotechnology industryıs largest-ever acquisition. During Mr.
Sharerıs tenure as CEO, Amgen grew its annual revenues from over $3 billion in
1999 to revenues approaching $16 billion in 2011. Mr. Sharer currently serves on
the boards of Chevron and Northrop Grumman and previously was a director of 3M.
"Kevin has had a long affiliation with Foundation and we are excited to
bring him on board. He has already been adding his operational expertise and
strategic guidance to our portfolio companies," said Andrew Firlik, Managing
Partner of Foundation Medical Partners. "In addition, his network in the
healthcare corporate community is an important source of deal flow and resources
to help build early stage companies."
Mr. Sharer joins the investment
team at Foundation Medical Partners that includes partners Andrew Firlik, Lee
Wrubel, and Ted Laufik. The firm actively manages over $200 million in venture
capital targeted toward start-up and early-stage companies. Foundation has
remained exclusively focused on the healthcare technology market since the firm
was founded in 2001, with a current market capitalization of its healthcare
investments totaling approximately $2.0 billion.
Foundation Medical Partners is a national venture
capital investment firm formed in 2001 with the vision of bringing together
cutting edge healthcare expertise with deep company building experience.
Foundation specializes in early stage venture capital for healthcare technology
companies. Foundation Medical Partners was an early, active venture investor in
many companies that subsequently went public or were acquired in strategic
transactions, such as AtriCure (NASDAQ: ATRC), CardioNet (NASDAQ: BEAT),
Combinatorx (NASDAQ: ZLCS), Immunicon (NASDAQ: IMMC, later acquired by Johnson &
Johnson), Northstar Neuroscience (NASDAQ: NSTR, later acquired by St. Jude
Medical), and Visiogen (acquired by Abbott), as well as a portfolio of other
market-leading privately held firms.
For press correspondence,
ANDREW D. FIRLIK, MD
Foundation Medical Partners
105 Rowayton Avenue
Rowayton, CT 06853